对于婴儿发作的性饮食
Morris H Scantlebury1,2,3,4, Anamika Choudhary1,2,3, Andy Cheuk-Him Ng1,2,4
1Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Epilepsia open
|October 29, 2025
概括
性饮食 (KD) 在标准治疗失败时显示出对婴儿发作综合征 (IESS) 的承诺. 动物研究揭示了KD机制,包括肠道微生物组和大脑化学变化,为新疗法提供了潜力.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 儿科神经学 儿科神经学
背景情况:
- 婴儿发作综合征 (IESS) 影响婴儿,约50%的婴儿对第一线疗法如维加巴林和激素治疗没有反应.
- 对IESS的二线治疗缺乏共识,需要探索替代治疗策略.
- 性饮食 (KD) 在耐药性中被认为是有效的,并在IESS病例中显示出潜力.
研究的目的:
- 根据动物模型,审查对基因饮食在IESS中的作用机制的当前理解.
- 通过改变呼吸来突出KD在诱导大脑酸化中的作用.
- 在KD治疗的IESS动物模型中探索关于肠道微生物组和托-氨酸-氨酸路径改变的最新发现.
主要方法:
- 审查现有的文献和动物模型研究关于性饮食和IESS.
- 分析与KD对呼吸,大脑pH,肠道微生物群和神经递质通路的影响有关的数据.
- 综合发现,以阐明KD在IESS中的治疗机制.
主要成果:
- 性饮食会影响呼吸,导致大脑酸化,这是一个潜在的抗机制.
- 肠道微生物组的变化与KD对IESS的疗效有关.
- 在IESS模型中,托-氨酸-氨酸通路受到KD的影响,这表明神经化学调制.
结论:
- 了解IESS中的KD机制为开发新疗法提供了基础.
- 准肠道微生物群和神经化学途径可能为耐火性IESS提供新的治疗途径.
- 对KD多面影响的进一步研究可能会导致更容易获得和更有效的IESS疗法.
更多相关视频
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
21.0K
07:01Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
9.4K
相关概念视频
01:13Seizures: Classification
1.3K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.3K
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
1.2K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K
01:14Antiepileptic Drugs: Glutamate Antagonists
884
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
884
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
806
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
806
01:24Epilepsy and Seizures: Overview
1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
01:20Antiepileptic Drugs: Potassium Channel Activators
624
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
624